Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3436 AL 3450

The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis

Liu L, Li J, Ke Y, Zeng X, Gao J, Ba X, Wang R.

Cell Mol Life Sci. 2022 Jan 9;79(1):60. doi: 10.1007/s00018-021-04109-w.

The role of junctophilin proteins in cellular function

Lehnart SE, Wehrens XHT.

Physiol Rev. 2022 Jul 1;102(3):1211-1261. doi: 10.1152/physrev.00024.2021. Epub 2022 Jan 10.

Neuroprotective potential of Celastrus paniculatus seeds against common neurological ailments: a narrative review

Sankaramourthy D, Sankaranarayanan L, Subramanian K, Sadras SR.

J Complement Integr Med. 2022 Jan 10;20(3):530-536. doi: 10.1515/jcim-2021-0448. eCollection 2023 Sep 1.

Pharmacological Management of Apathy in Dementia

Azhar L, Kusumo RW, Marotta G, Lanctôt KL, Herrmann N.

CNS Drugs. 2022 Feb;36(2):143-165. doi: 10.1007/s40263-021-00883-0. Epub 2022 Jan 10.

Glutathione in Brain Disorders and Aging

Iskusnykh IY, Zakharova AA, Pathak D.

Molecules. 2022 Jan 5;27(1):324. doi: 10.3390/molecules27010324.

Deep brain stimulation for chorea-acanthocytosis: a systematic review

Wu Y, Xu YY, Gao Y, Li JM, Liu XW, Wang MQ, Deng H, Xiao LL, Ren HB, Xiong BT, Pan W, Zhou XW, Wang W.

Neurosurg Rev. 2022 Jun;45(3):1861-1871. doi: 10.1007/s10143-022-01735-1. Epub 2022 Jan 12.

DNA Methylation: A Promising Approach in Management of Alzheimer's Disease and Other Neurodegenerative Disorders

Kaur G, Rathod SSS, Ghoneim MM, Alshehri S, Ahmad J, Mishra A, Alhakamy NA.

Biology (Basel). 2022 Jan 7;11(1):90. doi: 10.3390/biology11010090.

Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review

Man YL, Sanna G.

Brain Sci. 2022 Jan 11;12(1):91. doi: 10.3390/brainsci12010091.

Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease

Maity S, Komal P, Kumar V, Saxena A, Tungekar A, Chandrasekar V.

Int J Mol Sci. 2022 Jan 11;23(2):780. doi: 10.3390/ijms23020780.

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders

Kibret BG, Ishiguro H, Horiuchi Y, Onaivi ES.

Int J Mol Sci. 2022 Jan 17;23(2):975. doi: 10.3390/ijms23020975.

Nanotechnology in Improving the Treatment of Huntington's Disease: a Systematic Review

Valadão KMG, Luizeti BO, Yamaguchi MU, Issy AC, Bernuci MP.

Neurotox Res. 2022 Apr;40(2):636-645. doi: 10.1007/s12640-021-00468-1. Epub 2022 Jan 21.

Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders

Kabir MT, Rahman MH, Shah M, Jamiruddin MR, Basak D, Al-Harrasi A, Bhatia S, Ashraf GM, Najda A, El-Kott AF, Mohamed HRH, Al-Malky HS, Germoush MO, Altyar AE, Alwafai EB, Ghaboura N, Abdel-Daim MM.

Biomed Pharmacother. 2022 Feb;146:112610. doi: 10.1016/j.biopha.2021.112610. Epub 2022 Jan 4.

The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases

Klonarakis M, De Vos M, Woo EK, Ralph LT, Thacker JS, Gil-Mohapel J.

Neurosci Biobehav Rev. 2022 Apr;135:104541. doi: 10.1016/j.neubiorev.2022.104541. Epub 2022 Jan 19.

Exploring multifunctional antioxidants as potential agents for management of neurological disorders

Sindhu RK, Kaur P, Kaur P, Singh H, Batiha GE, Verma I.

Environ Sci Pollut Res Int. 2022 Apr;29(17):24458-24477. doi: 10.1007/s11356-021-17667-0. Epub 2022 Jan 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias